Michigan Initial Experience Using Tigertriever for Thrombectomy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHenry Ford Health System
About this trial
The purpose of this research study is to collect data about the effectiveness (i.e. how the device works) and safety (how safe it is to use such a device) of the Tigertriever in restoring blood flow by removing thrombus (or blood clot) from a large intracranial vessel (blood vessel in the brain) in patients experiencing ischemic stroke within 8 hours of symptom onset.
Eligibility criteria
Qualifiers
Patients admitted with large vessel occlusion (LVO) and treated with the Tigertriever, as per the approved indication.
Tigertriever was used as the first line treatment in the target vessel.
A signed informed consent.
Age ≥ 18.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Mechanical Thrombectomy
Treatment groups
150 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov